February 17, 2015
Syringe maker Retractable Technologies Inc. has claimed it deserves $5.65 million in prejudgment interest from rival Becton Dickinson & Co. on top of the $340 million it won in a false advertising and antitrust suit, saying Becton's persistent stall tactics justify the award.
February 12, 2015
Becton Dickinson & Co. urged a Texas federal judge on Thursday to nix a prejudgment interest award on a $340 million judgment against BD for attempting to monopolize the market for its safety syringes, saying antitrust law doesn't allow the award in Retractable Technologies Inc.'s case.
January 15, 2015
A Texas federal judge on Wednesday partially stayed an injunction against Becton Dickinson & Co. granted when the company was ordered to pay $340 million to Retractable Technologies Inc. for making false claims about its safety syringes, saying Becton does not have to notify health care providers that use but don't resell the syringes of its wrongdoing — for now.
December 19, 2014
A Texas federal judge denied Retractable Technologies Inc.'s attempt to add a charge of monopoly power to a jury's 2013 verdict against Becton Dickinson and Co., saying that Becton's declining 50 percent market share constituted a "proper basis" justifying the jury's conclusion that it lacked monopoly standing.
December 09, 2014
Becton Dickinson & Co. on Monday urged a Texas federal judge to stay an injunction granted when the company was ordered to pay $340 million to Retractable Technologies Inc. for making false claims about its safety syringes, saying absent a stay it will be deprived of its appeal of the injunction.
November 10, 2014
A Texas federal judge on Monday granted Retractable Technologies Inc.'s bid to recover profits from Becton Dickinson & Co. for falsely claiming its safety syringes had the "world's sharpest needle," but ruled that the $340 million RTI will get from trebling its jury win is enough.
September 30, 2014
A Texas federal judge on Tuesday rejected Becton Dickinson & Co.'s bid to ax a $113.5 million damages verdict in favor of Retractable Technologies Inc. and send the syringe market monopolization case back to a jury for a new trial, ruling that evidence presented during trial supported the jury's findings.
October 15, 2013
Becton Dickinson & Co. urged a Texas federal judge Friday to nix a $113.5 million damages verdict in favor of longtime patent litigation rival Retractable Technologies Inc. and send the syringe market monopolization case back to a jury for a new trial, claiming the company couldn't prove Becton Dickinson's alleged actions led to decreased competition.
September 20, 2013
A Texas federal jury on Thursday awarded Retractable Technologies Inc. $113.5 million in damages against longtime patent litigation rival Becton Dickinson & Co. after finding that the medical supply giant had attempted to monopolize the market for safety syringes.
September 10, 2013
Patent infringement can amount to anti-competitive conduct under federal antitrust law, a Texas federal judge ruled Monday, keeping intact a suit brought by Retractable Technologies Inc. against rival Becton Dickinson & Co. alleging a monopoly in the syringe industry.